Relief for pharma companies as API prices see a sharp fall

India's pharmaceutical industry, which is dependent on China for APIs, intermediates and bulk drugs, had seen an exponential price increase during Covid times. The rise in API prices continued until early this year. However, things have started to change, people in the know told ET.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/aTGh6FC
via IFTTT